Screener
Regenxbio RGNX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other comprehensive income (loss) | (5) | 12 | (188) | (9) |
| Comprehensive income (loss) | $22,704 | $(70,859) | $(67,530) | $(64,797) |
| Net income (loss) per share: | ||||
| Basic | $0.43 | $(1.38) | $(1.28) | $(1.26) |
| Diluted | $0.43 | $(1.38) | $(1.28) | $(1.26) |
| Weighted-average common shares outstanding: | ||||
| Basic | 52,820 | 51,483 | 52,625 | 51,423 |
| Diluted | 53,016 | 51,483 | 52,625 | 51,423 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's shares (diluted)?
- Regenxbio (RGNX) reported shares (diluted) of 53M in Q2 2026.
- How has Regenxbio's shares (diluted) changed year-over-year?
- Regenxbio's shares (diluted) increased by 3.0% year-over-year, from 51.5M to 53M.
- What is the long-term trend for Regenxbio's shares (diluted)?
- Over 4 years (2021 to 2025), Regenxbio's shares (diluted) has grown at a 4.8% compound annual growth rate (CAGR), from 170.9M to 206.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Regenxbio's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude